Annual report pursuant to Section 13 and 15(d)

INCOME TAXES (Tables)

v3.24.1
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
SCHEDULE OF INCOME TAXES

 

   

Year Ended

   

Year Ended

 
    December 31, 2023     December 31, 2022  
    £     £  
Current tax                
Corporation tax credit     1,088,729       1,720,000  
Total current tax credit     1,088,729       1,720,000  
                 
Reconciliation of loss before tax to the tax credit for the year                
Loss before tax     6,995,682       3,033,601  
                 
Loss on ordinary activities multiplied by the standard rate of tax of 23.5% (2022: 19%)     1,643,985       576,384  
                 
Adjustments in respect of prior years     45,136       154,422  
Non-deductible expenses     (1,497,764 )     (1,834,581 )
Super deductions     -       13,178  
Change in deferred tax asset     -       (186,879 )

Change in valuation allowance

    357,897      

(671,566

)
Foreign rate differential    

(29,318

)     -  
Other    

(233,096

)     -  
Additional allowance in respect of enhanced R&D relief     -       4,198,115  
Surrender of tax losses for R&D tax credit refund     -       (2,109,111 )
Adjustments relating to GAAP     (241,704 )     14,460  
R&D tax credits generated     1,043,593       1,565,578  
Current tax credit     1,088,729       1,720,000  
SCHEDULE OF COMPONENTS OF DEFERRED TAX ASSETS

Significant components of the Company’s deferred tax assets as of December 31, 2023 and 2022 are summarized below.

SCHEDULE OF COMPONENTS OF DEFERRED TAX ASSETS 

    2023     2022  
Deferred tax assets:                
Net operation losses   £ 4,357,668     £ 4,433,305  
Fixed asset     79,338       71,426  
Other     17,946       308,118  
Total deferred tax assets     4,454,952       4,812,849  
                 
Valuation allowance     (4,454,952 )     (4,812,849 )
                 
Net deferred tax asset, net of valuation allowance   £     £